Prodrugs of prostate specific membrane antigen (PSMA) inhibitor Grant US-11932664-B2 United States of America 19 Mar 2024
Mebendazole prodrugs with enhanced solubility and oral bioavailability Grant US-11712435-B2 United States of America 01 Aug 2023
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor Grant US-11325931-B2 United States of America 10 May 2022
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor Application US-10544176-B2 United States of America 28 Jan 2020
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor Application US-9988407-B2 United States of America 05 Jun 2018
Methods of treating retroviral infections and related dosage regimes Grant US-9956239-B2 United States of America 01 May 2018
Methods of treating retroviral infections and related dosage regimes Grant US-9694024-B2 United States of America 04 Jul 2017
Methods of treating retroviral infections and related dosage regimes Grant US-9278135-B2 United States of America 08 Mar 2016
PRODRUGS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITOR Application WO-2016022827-A1 World Intellectual Property Organisation (WIPO) 11 Feb 2016